Philip M. Rasmussen was one of the few American pilots to get into the air in the skies on Dec. 7, 1941. He was still in his ...

A holiday wishlist for all 32 NFL teams, featuring playoff hopes, quarterback chaos, and franchises begging for mercy.

The .22 Creedmoor takes the familiar 6.5 Creedmoor case and necks it down to accommodate a .22 caliber bullet. This transformation allows for the use of lighter, high-ballistic-coefficient projectiles ...

Mary Handeland, a real estate agent in Grafton, Wis., found a match on a dating app last year. He said that his name was Mike and that he was an engineer for a defense contractor in Texas. Within two ...

Oklahoma man allegedly fired bullet during Christmas Day target practice that fatally struck woman on porch, authorities say.

The four people, part of an anti-capitalist and anti-government group called the Turtle Island Liberation Front (TILF), were ...

Discovery now happens before search demand is visible in Google. In 2026, interest forms across social feeds, communities, and AI-generated answers – long before it shows up as keyword search volume.

The IDF said Haitham Ali Tabataba'i was killed in the strike. Israeli Prime Minister Benjamin Netanyahu and other officials reiterated their intention to block future Palestinian statehood ahead of ...

DETROIT – Michigan lawmakers are moving quickly on a bill that would require teens to verify their age before signing up for social media accounts. The bill also sets a usage curfew for minors and ...

Larian says that nothing AI-generated will appear in its games, and that it does not "develop concept art" with AI tools. When you purchase through links on our site, we may earn an affiliate ...

PARIS, Dec 9 (Reuters) - Renault (RENA.PA), opens new tab will jointly develop small, cheaper electric vehicles for Ford (F.N), opens new tab for the European market and will also team up to produce ...

Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...